FATE THERAPEUTICS INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Fate Therapeutics Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2016 to 2023.
  • Fate Therapeutics Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $95.5M, a 46029% increase year-over-year.
  • Fate Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $85K.
  • Fate Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $9.21M, a 98% decline from 2021.
  • Fate Therapeutics Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $453M, a 60.2% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $85K* -$9.12M Jan 1, 2023 Dec 31, 2023 10-K 2024-02-26
2022 $9.21M -$444M -98% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-26
2021 $453M +$170M +60.2% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $283M +$133M +88.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $150M +$9.15M +6.5% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-28
2018 $141M +$93.4M +197% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-24
2017 $47.4M -$10.4M -18% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $57.7M Jan 1, 2016 Dec 31, 2016 10-K 2019-03-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.